CIK 0001576280 · Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454139254
- Phone
- 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Azar Alex M II Director | Option exercise | +138 | 1,031 | ||
| 2026-11-12 | Azar Alex M II Director | Option exercise · Restricted Stock Units | −138 | 4,678 | ||
| 2026-11-09 | SAYER KEVIN R Director | Grant or award · Restricted Stock Units | +3,149 | 3,149 | ||
| 2026-11-09 | PARKS ROBERT Chief Accounting Officer | Grant or award · Restricted Stock Units | +18,893 | 18,893 | ||
| 2018-10-09 | SoftBank Group Capital Ltd 10% owner | Conversion | +2,033,990 | 2,033,990 | ||
| 2018-10-09 | SoftBank Group Capital Ltd 10% owner | Conversion · SERIES D PREFERRED STOCK | −2,033,990 | 0 |
Page 1 of 1 · 6 trades